Asia-Pacific Mitomycin C Market Analysis 2012-2017 and Forecast 2018-2023

ReportPage
Report ID
27752
Published Date
20-Mar
No of Report Page
103
Report Category
Pharmaceuticals and Healthcare
Editor's Rating
US $6,600.00
US $6,600.00
US $3,300.00

  • Report Details

    Snapshot
    Mitomycin C is an antibiotic which acts as a double-stranded DNA alkylating agent. It covalently crosslinks DNA, inhibiting DNA synthesis and cell proliferation It acts by way of reductive activation either through low pH or NAD(P)H:quinone oxidoreductase (DT-diaphorase) or NADH cytochrome c reductase (Mao et al.; Cummings et al.).
    The Asia-Pacific Mitomycin C market will reach xxx Millio

    More...
  • Table Of Content

    Table of Content
    1 Industry Overview
    1.1 Mitomycin C Industry
    1.1.1 Overview
    1.1.2 Development of Mitomycin C
    1.2 Market Segment
    1.2.1 By Product Type
    1.2.2 By Application
    1.3 Asia-Pacific Overview
    2 Major Companies List
    2.1 Kyowa-kirin (Company Profile, Products & Services, Sales Data etc.)
    2.2 Intas Pharmaceuticals (Company Profile, Products &

    More...
  • Inquiry Before Buying
    Inquiry Before Buying -
  • Request Sample
    Request For Sample